The outlook of companies tied to Viagra's past presents a intricate investment scenario . While the initial success generated substantial gains, generic competition have significantly impacted sales . Investing in connected pharmaceutical businesses now requires a discerning assessment of intellectual property safeguards, evolving patient changes,